MSD
LIVE

Serial Number

79443795

Owner

Merck Sharp & Dohme B.V.

Filing Date

Jan 15, 2026

Add to watchlist:

No watchlists yet
View on USPTO

MSD Trademark

Serial Number: 79443795

MSD is a trademark filed by Merck Sharp & Dohme B.V. on January 15, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Merck Sharp & Dohme B.V. (40 trademarks)

Waarderweg 39
HAARLEM 2031BN , NL

Entity Type: 26

Trademark Details

Filing Date

January 15, 2026

Registration Date

Not Registered

Goods & Services

Surgical apparatus and instruments for medical or veterinary use; medical instruments and apparatus for treating autoimmune, bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, urological, viral, infectious, fungal, bacterial, and parasitic diseases and disorders; inhalers for medical purposes, sold empty; injection and medical or veterinary infusion devices for administering pharmaceuticals; veterinary apparatus and instruments for dispensing pharmaceutical products, namely, drenching guns for animals and livestock, veterinary vaccine applicators, veterinary infusers and injectors, veterinary dosing devices, sutures, and temperature measuring systems for veterinary use

Educational services, namely, conducting programs in the fields of medicine, healthcare, pharmaceuticals, and animal health, and distribution of educational materials in connection therewith

Business support services to start-up companies in the pharmaceutical, healthcare, veterinary, and biomedical fields by providing workspace containing technology equipment; business information services in the fields of healthcare, pharmaceuticals, medicine, and animal health; providing incentive award programs through issuance and processing of loyalty points for purchase of a company's goods and services in the fields of healthcare, pharmaceuticals, medicine, and animal health; administration of a program for enabling participants to obtain discounts on products and services in the fields of healthcare, pharmaceuticals, medicine, and animal health; provision of business, marketing, product sales and commercial information relating to pharmaceutical, medical, veterinary and healthcare products via a global communications network; retail, wholesale, and online retail store services featuring vaccines, pharmaceuticals, healthcare products, medicines, and veterinary products; distribution of advertising, marketing and promotional material in the fields of healthcare, pharmaceuticals, medicines, and animal health; business research and data analysis in the field of pharmaceutical drug development

Providing information in the fields of healthcare, pharmaceuticals, medicines, and animal health, including via a website; charitable services, namely, providing medical, veterinary and healthcare services in the nature of providing medication use and management information and mental health and wellness information to patients and caregivers; veterinary services

Pharmaceutical preparations for the treatment of autoimmune, bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, urological, viral, infectious, fungal, bacterial, and parasitic diseases and disorders for human and veterinary use; human vaccine preparations; vaccines for veterinary use, namely, for the treatment of ruminants, porcines, equines, companion animals, aquaculture, and poultry; medicated supplements for foodstuffs for animals

Filing History

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 15, 2026 RFCR
NON-FINAL ACTION WRITTEN
May 14, 2026 CNRT
ASSIGNED TO EXAMINER
May 13, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 12, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 12, 2026 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 10, 2026 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Feb 12, 2026 SDRC